About Desert Hope
Services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; Other contracted prescribing entity
Type of Opioid Treatment
Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Anger management; Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Trauma-related counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency; The Joint Commission
Payment/Insurance/Funding Accepted
Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment
Special Programs/Groups Offered
Young adults; Adult women; Pregnant/postpartum women; Adult men; Seniors or older adults; Veterans; Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Self-help groups; Housing services; Mentoring/peer support
Other Services
Treatment for gambling disorder; Treatment for other addiction disorder
Education and Counseling Services
Individual counseling; Group counseling; Family counseling; Marital/couples counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults; Adults
Gender Accepted
Female; Male
Facility Vaping Policy
Vaping permitted without restriction
Ancillary Services
Case management service; Mental health services; Transportation assistance; Integrated primary care services; Suicide prevention services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; Other contracted prescribing entity
Type of Opioid Treatment
Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Anger management; Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Trauma-related counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency; The Joint Commission
Payment/Insurance/Funding Accepted
Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment
Special Programs/Groups Offered
Young adults; Adult women; Pregnant/postpartum women; Adult men; Seniors or older adults; Veterans; Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Self-help groups; Housing services; Mentoring/peer support
Other Services
Treatment for gambling disorder; Treatment for other addiction disorder
Education and Counseling Services
Individual counseling; Group counseling; Family counseling; Marital/couples counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults; Adults
Gender Accepted
Female; Male
Facility Vaping Policy
Vaping permitted without restriction
Ancillary Services
Case management service; Mental health services; Transportation assistance; Integrated primary care services; Suicide prevention services
